A N OVERVIEW OF MJCROBIOLOGICAL AND CLI NICAL ASpects of bone and joint infections was presented by Dr T Louie. The essential characteristics of osteomyelitis include a dhesive colonization of damaged bone. tissue substrate or biomaterials, eg, prosthetic orthopedic devices ( 1-3) . Chronic persistent infection where microbes are protected from host defenses and antimicrobial intervention by bacterial biofilms, devitalized tissue and foreign body effect become a formidable medical-surgical management problem (4-6).
Animal models of osteomyelitis have partially clarified pathogenesis. However, bone infection is generally ctifficult to initiate without concurrent tissue damage. introduction of sclerotic chemicals or foreign bodies (7-8). Animal models have shown that microbial synergy may be important in promoting infection in situations wher e polymicrobial contamination of bone occurs. Therapeutic studies of animal models of osteomyelitis have shown that beta-lactam antibiotics and vancomycin treatment, even for four weeks. does not result in sterilization of the infected site. Less conventional treatment options such as clindamycin, beta-lactams in combination with rifampin or rifampin plus a quinolone antimicrobial agent merit se1ious consideration in well designed clinical trials (9 , 1 0) .
The committee reviewed clinical trial options and concluded that management of the infected total hip and total knee prostheses, as well as other infected orthopedic devices, was of major clinical interest to infectious disease clinicians across Canada. Committee members indicated that the infected total hip replacement was the most common ctifficult to manage infectious disease problem facing both infectious ctisease clinicians. internists and orthopectic surgeons. The infected total hip replacement is ideally suited to a multi- centre clinical trial approach s ince each meclical centre, independently. will h ave only five to 20 cases per year. These a re insufficient numbers to allow s ingle medical centres to evaluate ctiagnostic and th erapeutic a pproach es in a reasonable time frame of two to tl1.ree years. It was proposed tl1.at the Canadian Infectious Disease Society in conjunction with the Canadian Orthopedic Association develop a clinical trial network to address outstanding infectious disease/orthopedic problem s. Specifically with respect to th e total hip replacement, the role of hospital infection control units should be examined as a clinical trials resource since procedurerelated infection rates are monitored across Canada.
Diagnostic and therapeutic approaches to the management of infected total hip replacement in a clinical !.rials setting were discussed .
DIAGNOSIS
Diagnostic approaches to separate mechanical loosening versus infection or bot.h were reviewed (11 ,12) . Combinations of preoperative aspiration culture. multiple-site intraoperative cultures. t.he e1yt.hrocyte sectimentation rale. plain x-rays. techn etium 99 bone scans.
gallium scans, 111 indium-labelled white blood cell scans. indium-labelled polyclonal IgG scans, computed tomography scans a nd m agn etic resonance imaging scans have been investigated . It was concl uded that no single test is both highly sensitive and specific for total hip replacement infection (13). However, several combinations and a decision tree approach a re recommended (11) . While laboratory tests a re helpful in guicting m a nagement. clinical observation over time in conjunction with adequate cultures are essential.
THERAPY
An observational study to monitor current therapy in Can adian hospitals was suggested. The proportion of patients managed by debridement and antibiotics or by one-and two-stage revisions would be tabulated. Outcom es would be used to idenwy problems and potential solutions to total hip replacement infection problems.
Previous studies have shown that a ntibiotic treatment and s uppression along with debridement without prosthesis removal results in effective suppression of infection in the minority of patien ts (14) .
One-and two-stage revision s urgery, in conjunction with varying lengths of intravenous antibiotic therapy have shown that progressively superior results of recon stru ction surgery are attained with a combination of prosthetic removal and debridem ent plus six week s of aggressive intravenous antibiotic therapy followed by prosthetic insertion. With certain pathogens, such as Pseudomonas aeruginosa and other Gram-negative bacilli, some investigators have recommended extended durations of observation following antibiotic treatment prior to prosthetic insertion ( 1 7).
Clinical trials on the most appropriate antimicrobials. eg. beta-lactams vers us other antimicro bial classes . eg. macrolides for Gran1-positive infecting pathogens. combinations of antibiotics. or the investigation of new antimicrobials should be developed. Combinations which show promise in animal models should be considered (8-10).
PREVENTION
Most committee members felt that a prophylaxis trial would be too difficult to conduct because of the la rge number of patients required to show significant differences between antimicrobial agents. Currently. in - fection rates are approximately 1% in Canadian hospitals. Other variables including HEPA-filtered opera ting room air, antimicrobial containing wound iniga nts. age. co-existing infection at other sites and underlying disease need to be considered in prophylaxis trials. Finally, the use of different bone cements which h a rden at va rying temperatures should be investigated as an infection variable. Currently, the most commonly used bone cement hardens at 70°C a temperature tl1 at m ay compromise host defenses.
The role of antibiotic-containing bone cem ents in orthopedic surgery should also be investigated. Different clinical trials each with small numbers of patients have shown that two-stage revisions with and without gentamicin-containing bone cem ent h ave yielded s imilar outcomes (13. 15, 16 .18 , 19) . Comparative tr·i-als with larger numbers of patients would be of practical interest.
Other bone and joint infections including acute h ematogenous osteomyelitis. the diabetic foot, chronic osteomyelitis and fracture-associated infections were considered for purposes of clini cal tJials. However. the infected hip prosthesis, while low in number. is a long term medical problem which disproportionately consu mes health care resources and creates significant deterioration in qua lity of life . It is hoped that some of the above issues can be addressed by multicentre clinical tiial(s) in the n ear future.
